Olivier Taelman
Fortuna: 21 608 $ al 30/06/2026
Fortuna: 21 608 $ al 30/06/2026
Olivier Taelman currently works at Nyxoah SA, as Chief Executive Officer & Executive Director from 2020.
Mr. Taelman also formerly worked at Nevro Corp., as Business Director-Neuromodulation from 2013 to 2015 and Autonomic Technologies, Inc., as Vice President-Europe from 2015 to 2019.
Mr. Taelman received his undergraduate degree from Hasselt University and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NYXOAH SA 0,01 % | 01/03/2026 | 12.500 ( 0,01 % ) | 21 608 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NYXOAH SA | Director Ejecutivo | 01/11/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
Autonomic Technologies, Inc.
Autonomic Technologies, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for the treatment of severe headache autonomic disorder | Corporate Officer/Principal | 01/11/2019 |
| NEVRO CORP. | Corporate Officer/Principal | 01/12/2015 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Autonomic Technologies, Inc.
Autonomic Technologies, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for the treatment of severe headache autonomic disorder | Health Technology |
Hasselt University
Hasselt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nevro Corp.
Nevro Corp. Medical SpecialtiesHealth Technology Operates as a medical device company | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nyxoah SA
Nyxoah SA Medical SpecialtiesHealth Technology Manufactures neurostimulation devices for treating obstructive sleep apnea | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.